Roche's blockbuster cancer drug Avastin has been spurned once again by Britain's health cost watchdog NICE, this time as a treatment for breast cancer.
UK's NICE rejects Roche's Avastin in breast cancer
Search Results
FDA cracks down on 5 makers of e-cigarettes
The U.S. Food and Drug Administration sent warnings to five makers of electronic cigarettes for marketing them illegally as stop-smoking aids and said on Thursday it intends to regulate the products as drugs.
Study backs prostate screening for high risk men
Men who have a certain genetic variations that put them at higher risk of prostate cancer may benefit from regular screening for the disease, a study by British scientists found Friday.
Study: Flamboyant male dancing attracts women best
John Travolta was onto something. Women are most attracted to male dancers who have big, flamboyant moves similar to the actor's trademark style, British scientists say in a new study.
US says electronic cigarettes must get government approval
So-called electronic cigarettes cannot be sold in the United States without getting regulatory approval, the Food and Drug Administration said Thursday.
Developers of cancer pill tout biopsy/tweak method
Tests of tumor samples taken before and after treatment with an experimental melanoma pill helped researchers find the right dose in early stage testing, an approach that may boost the drug's chances of success and aid in developing others, co...
UK's NICE wants more data on BMS schizophrenia drug
Britain's healthcare cost watchdog said it was unable to recommend use of Bristol-Myers Squibb's schizophrenia drug Abilify in children aged 15 to 17 and has asked for more information on its effectiveness.
US court lifts ban on state-funding for stem cell research
A US appeals court suspended Thursday a ban on state-funding for embryonic stem cell research pending a full appeal of the case, in a major boost to President Barack Obama's administration.
Risks of old, new diet drugs face U.S. scrutiny
The risks of a potential new diet pill and a 13-year-old weight-loss medicine face U.S. scrutiny next week as medical experts consider if the drugs' benefits outweigh possible side effects.
FDA warns of deadly side effect with imaging drugs
Federal health regulators are warning doctors that a class of injectable drugs used in MRI medical imaging scans can cause a rare and sometimes fatal condition in patients with kidney disease.
CDC: Adults eating less fruit, not enough veggies
An apple a day? Apparently not in the United States.
Post new comment